Logo
Your free order overview
You currently have not items to display
Logo
Your contact details

This is a required field

Logo
Thank you!

Thank you for choosing Janssen Medical Cloud for ordering your materials.

/
Message from Darzalex team

Message from Darzalex team

References

  • One-Year Update of a Phase 3 Randomized Study of Daratumumab Plus Bortezomib, Melphalan, and Prednisone (D-VMP) Versus Bortezomib, Melphalan, and Prednisone (VMP) in Patients (Pts) with Transplant-Ineligible Newly Diagnosed Multiple Myeloma (NDMM): Alcyone https://doi.org/10.1182/blood-2018-156
  • AcasterS, et al. Support Care Cancer. 2013:21:599-607.
dara_new-logo

CP-145523

Logo
This site is published by ©Johnson & Johnson Innovative Medicine NV which is solely responsible for its content. It is intended for European, Middle Eastern and African Healthcare professionals.
Johnson & Johnson Pharmaceutica NV
Legal NoticeCookie PolicyPrivacy Policy
Cookie Settings